RichardJRodehefferMD
Cardiology • Rochester, MNAdult Congenital Heart Disease, Heart Failure & Transplantation
Professor of Medicine Mayo Clinic
Dr. Rodeheffer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Summary
- My focus is in clinical care and research in the area of heart failure and cardiac transplantation. On coming to Mayo Clinic in 1987, I co-founded our transplnat program and founded our Heart Failure Clinic.
Education & Training
Johns Hopkins UniversityFellowship, Cardiovascular Disease, 1982 - 1983- Johns Hopkins UniversityResidency, Internal Medicine, 1977 - 1981
University of Rochester School of Medicine and DentistryClass of 1977
Certifications & Licensure
WI State Medical License 2014 - 2025
MN State Medical License 1987 - 2024
TN State Medical License 1984 - 1987
MD State Medical License 1979 - 1985- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Prevalence of Asymptomatic Ventricular Dysfunction Start of enrollment: 1997 Jan 01
Publications & Presentations
PubMed
- Association of cardiac biomarkers with long-term cardiovascular events in a community cohort.Robert A Churchill, Benjamin R Gochanour, Christopher G Scott, Jeffrey W Meeusen, Vlad C Vasile, Richard J Rodeheffer, Allan S Jaffe> ;Biomarkers. 2024 Apr 26
- Inhibition of angiogenesis in the management of refractory gastrointestinal bleeding in patients with LVAD support.Inglis, S., Schettle, S., Villavicencio, M., Rosenbaum, A., Asleh, R., Iyer, V., Spencer, P., Rodeheffer, R., Kushwaha, S., Behfar, A.> ;Artificial Organs. 2023 Dec 22
- 1 citationsReassessing the clinical significance of electrocardiographically unrecognized myocardial infarctions: Radionuclide infarct size and its impact on long-term prognosis.Khawaja Afzal Ammar, Richard J Rodeheffer> ;Annals of Noninvasive Electrocardiology. 2023 Nov 1
- Join now to see all
Other
- Development of malignancy following solid organ transplantationRodeheffer RJ, Brennan DC, Ambinder RF
http://www.uptodate.com/contents/development-of-malignancy-following-solid-organ-transplantation
UpToDate, Wolters Kluwer Health - 2013-04-18
Authored Content
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Join now to see all
Press Mentions
Diabetes Kann Unabhängig Zu Herzinsuffizienz Führen, Wie Eine Bevölkerungsstudie ZeigtJanuary 6th, 2020- Selon Une Étude Portant Sur Une Population, Le Diabète Peut Entraîner Indépendamment Une Insuffisance CardiaqueJanuary 6th, 2020
Grant Support
- Prevalence Of Asymptomatic Ventricular DysfunctionNational Center For Research Resources2004–2005
- Prevalence Of Asymptomatic Ventricular DysfunctionNational Heart, Lung, And Blood Institute2004
- Prevalence Of Asymptomatic Ventricular DysfunctionNational Heart, Lung, And Blood Institute1997–2003
- Prevalence Of Asymptomatic Ventricular DysfunctionNational Center For Research Resources2000–2002
Professional Memberships
- Fellow
- Member
Hospital Affiliations
Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
